Catalog Advanced Search
199 Results
-
Includes a Live Web Event on 10/22/2026 at 11:00 AM (PDT)
Content provided by Roche (No CE credits offered)
Webinar Description:
Neonatal and pediatric sepsis present unique clinical challenges, ranging from non-specific symptoms to the limitations of traditional blood cultures in tiny patients. This sponsored webinar explores how diagnostic strategies and biomarkers, including Procalcitonin (PCT) and Interleukin-6 (IL-6) can help cut through the clinical noise. Join us to learn about early detection, enable targeted therapies, and safely reduce empiric antibiotic use in our most vulnerable patients.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Roche for this sponsored webinar.
Emin Maltepe, MD, PhD
Professor of Pediatrics
University of California San Francisco
Emin Maltepe, MD, PhD, is a Professor of Pediatrics at UCSF. His research laboratory studies mechanisms whereby hypoxia signaling pathways regulate normal development, contribute to the origins of pregnancy complications, and drive disease processes such as pulmonary hypertension and retinopathy of prematurity in newborn infants. Additionally, he is a co-founder of the Initiative for Pediatric Drug and Device Development (www.ipd3.org), a multi-institutional collaborative comprised of leaders in pediatrics and pharmaceutical sciences that functions as a ”one-stop-shop” to advance drug and device development for pediatric indications. In this capacity, the collaborative has been working with non-profit and industry sponsors on multiple fronts, including neurotherapeutics for birth asphyxia, novel oxygen delivery biotherapeutics for treatment of hemorrhagic shock, as well as cardioprotective agents for infants undergoing repair of congenital heart defects. He is additionally helping advise the development of novel diagnostic modalities specifically targeting sepsis as well as brain injury in newborn infants.
-
Includes a Live Web Event on 09/22/2026 at 11:00 AM (PDT)
Content provided by Abbott (No CE credits offered)
Webinar Description:
When sepsis patients move between care settings, every handoff matters. In this sponsored webinar, discover why care transitions break down, how lactate monitoring can reveal early signs of deterioration, and how data-driven communication empowers care teams. Explore proven strategies, smarter handoffs, and innovative technologies that help reduce readmissions and deliver safer, more connected recovery.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Abbott for this sponsored webinar.
Laurence Busse, MD, MBA, FCCM
Associate Professor of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine
Emory University
Laurence Busse, M.D., MBA, FCCM, is a Distinguished Physician and an Associate Professor of Medicine within the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine at Emory University. He is boarded in Internal Medicine and Critical Care Medicine. Dr. Busse served as the Medical Director of Critical Care at Emory Johns Creek Hospital and the Site Director of the Emory Critical Care Center (ECCC) for Johns Creek, until turning his attention to medical education and increasing access to clinical trials for patients in underserved areas. To this end, Dr. Busse founded and now leads the Satellite Trials Group of Emory (STaGE), a multi-site distributed clinical trials platform that brings together investigators from multiple Emory locations in the execution of translational research outside of traditional academic settings. Dr. Busse’s research focuses on sepsis and septic shock, and the role that novel therapeutics and theragnostics play in disease management. Dr. Busse is a recipient of the Emory Critical Care Center’s Timothy G. Buchman Award in Transformational Leadership. He is a Fellow of the American College of Critical Care Medicine.
-
Includes a Live Web Event on 09/16/2026 at 7:00 AM (PDT)
Free annual, virtual sepsis conference featuring subject matter experts across disciplines
Description:
The Sepsis Alliance Summit returns this September for its 7th year, bringing together thousands of healthcare professionals for a free, dynamic, virtual two‑day event. This year’s program features forward‑looking presentations from clinicians, researchers, innovators, patient advocates, and national leaders who are shaping the future of sepsis care.
Healthcare professionals can earn free AMA PRA Category 1 Credit(s)™ or RN CE credits through engaging, practice-focused sessions that explore the latest science, technologies, and system‑level strategies driving improvement in sepsis outcomes.Learning Objectives:
At the end of this event, the learner should be able to:
- Differentiate current sepsis definitions, diagnostic tools, and clinical criteria across diverse populations, including pediatric and hospital-acquired cases;
- Describe evidence-based strategies that strengthen early recognition, timely intervention, antimicrobial stewardship, and post-discharge monitoring to improve outcomes;
- List system-level drivers of quality improvement, such as SEP-1, CDI, HVBP, certification pathways, and collaborative models which can be developed into sustainable sepsis care programs;
- Evaluate innovative tools, including artificial intelligence, advanced diagnostics, and media-based education, to enhance personalized sepsis management;
- Apply trauma-informed approaches that address the experiences of co-survivors and foster healthcare environments that support patients, families, and providers.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
-
Content provided by Diasorin (No CE credits offered)
Webinar Description:
Sepsis remains a leading cause of mortality, requiring rapid and accurate diagnosis to guide timely treatment. Yet, many cases originate from overlooked sources, including gastrointestinal infections that can progress to bloodstream infections. This sponsored webinar will explore how a syndromic molecular approach can close critical diagnostic gaps, enabling earlier detection of pathogens and resistance markers. Attendees will learn how the LIAISON PLEX® BSI portfolio delivers flexibility, comprehensive coverage, and actionable results to support frontline clinical decisions. In addition, we will highlight the importance of pathogen-level surveillance and data tracking tools in improving antimicrobial stewardship, infection control strategies, and hospital performance metrics.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Diasorin for this sponsored webinar.
Michelle Tabb, PhD
Chief Scientific Officer
Diasorin
Michelle Tabb, PhD, serves as Chief Scientific Officer for the molecular division of Diasorin, where she leads global scientific strategy and innovation in molecular diagnostics. With over two decades of experience in clinical microbiology, molecular genetics, and assay development, Dr. Tabb has led the design and commercialization of over 30 FDA-cleared and CE-marked diagnostic assays while serving in Focus Diagnostics, Quest Diagnostics, and ultimately within Diasorin. Her development experience includes real-time PCR-based platforms for infectious disease and oncohematology applications. She is a co-inventor on 19 U.S. patents and has extensive expertise in nucleic acid detection technologies, regulatory strategy, and translational research. Dr. Tabb leads the Scientific Affairs Department and chairs Diasorin’s Infectious Diseases Scientific Advisory Board. She provides strategic oversight for scientific publications, external collaborations, and technology evaluations. She earned her Ph.D. in the Department of Microbiology and Molecular Genetics at UC Irvine, followed by postdoctoral studies in the fields of gene expression and drug metabolism in the Department of Developmental Biology at UC Irvine.
-
Content provided by Diasorin (No CE credits offered)
Webinar Description:
Sepsis remains a leading cause of mortality, requiring rapid and accurate diagnosis to guide timely treatment. Yet, many cases originate from overlooked sources, including gastrointestinal infections that can progress to bloodstream infections. This sponsored webinar will explore how a syndromic molecular approach can close critical diagnostic gaps, enabling earlier detection of pathogens and resistance markers. Attendees will learn how the LIAISON PLEX® BSI portfolio delivers flexibility, comprehensive coverage, and actionable results to support frontline clinical decisions. In addition, we will highlight the importance of pathogen-level surveillance and data tracking tools in improving antimicrobial stewardship, infection control strategies, and hospital performance metrics.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Diasorin for this sponsored webinar.
Michelle Tabb, PhD
Chief Scientific Officer
Diasorin
Michelle Tabb, PhD, serves as Chief Scientific Officer for the molecular division of Diasorin, where she leads global scientific strategy and innovation in molecular diagnostics. With over two decades of experience in clinical microbiology, molecular genetics, and assay development, Dr. Tabb has led the design and commercialization of over 30 FDA-cleared and CE-marked diagnostic assays while serving in Focus Diagnostics, Quest Diagnostics, and ultimately within Diasorin. Her development experience includes real-time PCR-based platforms for infectious disease and oncohematology applications. She is a co-inventor on 19 U.S. patents and has extensive expertise in nucleic acid detection technologies, regulatory strategy, and translational research. Dr. Tabb leads the Scientific Affairs Department and chairs Diasorin’s Infectious Diseases Scientific Advisory Board. She provides strategic oversight for scientific publications, external collaborations, and technology evaluations. She earned her Ph.D. in the Department of Microbiology and Molecular Genetics at UC Irvine, followed by postdoctoral studies in the fields of gene expression and drug metabolism in the Department of Developmental Biology at UC Irvine.
-
Join us for this year's Maternal Sepsis Week webinar!
Description:
Maternal sepsis remains a leading and preventable cause of severe morbidity and mortality, yet early warning signs are often missed during the most vulnerable moments of pregnancy, birth, and postpartum recovery. This special Maternal Sepsis Week webinar brings together clinical insights and real-world scenarios to illuminate how delays in recognition, escalation, and treatment contribute to rapid deterioration in maternal patients. Dr. Bauer will walk through evidence-based approaches to timely intervention, including practical strategies for initiating treatment bundles and coordinating multidisciplinary response. The webinar also highlights what happens after the acute crisis, outlining key components of follow-up care that support physical healing, mental health, and long-term recovery for survivors. Attendees will leave with actionable tools to strengthen maternal safety practices across settings and reduce preventable harm during the perinatal period.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe three delays that lead to maternal death from sepsis;
- Summarize recommended treatment for maternal sepsis;
- Review elements for follow-up after maternal sepsis to aid in recovery.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Melissa Bauer, DO
Associate Professor of Anesthesiology and Population Health Sciences
Duke University Medical Center
Melissa Bauer, DO, is dual fellowship–trained in critical care and obstetric anesthesiology, and is an Associate Professor of Anesthesiology and Population Health Sciences at Duke University Medical Center. Dr. Bauer is independently funded by the National Institutes of Health through the Eunice Kennedy Shriver National Institute of Child Health and Human Development, where her work is focused on reducing maternal mortality and morbidity due to maternal sepsis.
Dr. Bauer’s research centers on the early identification and treatment of maternal sepsis and the use of patient and community engagement strategies to improve maternal care. She recently served as Chair of the national Alliance for Innovation on Maternal Health (AIM) and American College of Obstetricians and Gynecologists (ACOG) Sepsis in Obstetrical Care Patient Safety Bundle Workgroup. Dr. Bauer has also led the statewide implementation efforts of the maternal sepsis safety bundle in Michigan and serves as a consultant for multiple states on maternal sepsis bundle implementation and quality improvement initiatives.
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
All individuals in control of content for this activity disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/21/2026
This webinar highlights learnings that were incorporated into the IPSO Change Package as a practical roadmap for teams seeking to improve reliability in sepsis identification, treatment, and follow-up. Attendees will learn how to apply change concepts, test improvements using quality improvement methods, and align multidisciplinary teams around shared goals. The session will also address common implementation challenges and strategies for sustaining gains over time.
Description:
Sepsis remains a leading cause of morbidity and mortality in children, yet variation in care persists. From 2017 – 2023, the Children’s Hospital Association (CHA) Improving Pediatric Sepsis Outcomes (IPSO) collaborative engaged 66 children’s hospitals in a quality improvement (QI) initiative to reduce sepsis-attributable mortality. Following a learning health systems model, IPSO established and supported the implementation of evidence-based care bundles to improve early recognition and timely treatment of sepsis. Utilizing QI tenets, advanced data analytics, and national collaboration, IPSO’s approach accelerated learning, successfully improving compliance with sepsis care processes, resulting in reduced care disparities, health care utilization, and mortality.
This webinar highlights learnings that were incorporated into the IPSO Change Package as a practical roadmap for teams seeking to improve reliability in sepsis identification, treatment, and follow-up. Attendees will learn how to apply change concepts, test improvements using quality improvement methods, and align multidisciplinary teams around shared goals. The session will also address common implementation challenges and strategies for sustaining gains over time.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the key components of the IPSO Change Package and how they address common sources of variation in pediatric sepsis identification, treatment, and follow‑up care;
- Apply selected change ideas from the Sepsis Change Package to a local context using quality improvement methods to improve reliability of sepsis care;
- Identify strategies for engaging multidisciplinary teams and sustaining improvements in sepsis performance over time.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sarah Kandil, MD
Associate Professor of Pediatrics at Yale New Haven Children’s Hospital
Yale School of Medicine
Sarah Kandil, MD, is the Deputy Quality and Safety Officer and Associate Professor of Pediatrics at Yale New Haven Children’s Hospital. She served on the IPSO leadership group and research workgroup and is now the Co-Chair (2026) of the Pediatric Sepsis Community of Practice Steering Committee, where she supports national efforts to improve pediatric sepsis care through quality and safety leadership.
Melissa Schafer, MD
Professor of Pediatrics
Upstate Golisano Children’s Hospital
Melissa Schafer, MD, is the Director of Pediatric Hospital Medicine and Professor of Pediatrics at Upstate Golisano Children’s Hospital in Syracuse. She is a member of the Pediatric Sepsis Community of Practice Steering Committee and contributes clinical expertise to advancing sepsis care improvement initiatives.
Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
All individuals in control of content for this activity disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
AlgoDx Sponsored Webinar: SEP-1 Made Simple: Practical Strategies for Compliance and Better Outcomes
CMS SEP-1 compliance can feel overwhelming, but it doesn't have to be. This sponsored webinar is designed is designed to help U.S. healthcare leaders improve sepsis quality scores while supporting clinical teams and hospital financial performance.
Description:
CMS SEP-1 compliance can feel overwhelming, but it doesn't have to be. This sponsored webinar is designed to help U.S. healthcare leaders improve sepsis quality scores while supporting clinical teams and hospital financial performance.
In this session, you'll learn:
- How to streamline SEP-1 bundle compliance within existing clinical workflows
- How an EHR-embedded sepsis management solution enables early detection and compliance
- Actionable steps to boost quality scores and strengthen your bottom line
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sepsis Alliance gratefully acknowledges the support provided by AlgoDx for this webinar.
David Becedas, M Sc Pharm, MBA
Chief Executive Officer
AlgoDx
David Becedas, M Sc Pharm, MBA, has 25 years of experience driving commercial growth and clinical development in life sciences industries and most recently served as Director at Chiltern, which was acquired by Labcorp.
Pelle Conradi, MD
Chief Medical Officer
Pelle Conradi, MD, Chief Medical Officer at AlgoDx, is an engaged ICU physician dedicated to clinical excellence who champions leveraging cutting-edge AI to advance sepsis care, safety, and quality.
Magnus Pierrau, M Sc ML
Head of ML and Backend Engineering
Magnus Pierrau, M Sc ML, is an experienced ML engineer with a background in defense and security research as well as medtech, who combines research with practical applications, focusing on data and model development.
Bailey Larson, BSN, RN, CV-BC
Sr. Clinical Product Specialist
AlgoDx
Bailey Larson, BSN, RN, CV-BC, is an innovative sepsis expert with proficiency in sepsis data analysis to drive multidisciplinary process changes, actively engaging in reimbursement, length of stay, education, and research.
-
Recorded On: 04/09/2026
Join the authors of the 2026 Surviving Sepsis Campaign (SSC) Adult Guidelines for a conversational fireside chat highlighting the latest updates to the global recommendations.
Description:
Join the authors of the 2026 Surviving Sepsis Campaign (SSC) Adult Guidelines for a conversational chat highlighting the latest updates to the global recommendations. The session will begin with a brief overview of how the multidisciplinary, internationally representative panels developed the new guidelines. Faculty will then outline the most significant changes since 2021 and the evidence that informed those updates. The discussion will focus on how the revised recommendations shape early recognition and management of sepsis and septic shock across diverse care settings. Practical insights on applying the guidelines, including considerations for low‑resource environments, will help participants translate the updates into everyday practice.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the development process for the 2026 Surviving Sepsis Campaign (SSC) Adult Guidelines, including how multidisciplinary and global perspectives informed the recommendations;
- Interpret the updated recommendations and their implications for early recognition and management of sepsis and septic shock across diverse clinical settings;
- Apply practical strategies for implementing the guideline updates in everyday practice, including considerations for adapting care in low‑resource environments;
- Identify key updates and changes from the 2021 guidelines and the evidence that shaped these revisions.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Hallie Prescott, MD, MSc
Professor of Internal Medicine, Division of Pulmonary Critical Care
University of Michigan
Hallie Prescott, MD, MSc, is a Professor of Internal Medicine in the Division of Pulmonary Critical Care within Michigan Medicine and a Staff Physician at the Ann Arbor Veterans Affairs Medical Center. She is the physician lead on the HMS Sepsis and Mi-COVID19 Initiatives. Hallie completed medical school, residency, and chief residency at Ohio State University, and fellowship and Masters in Health Services Research at the University of Michigan. She is interested in sepsis, performance measurement, and long-term outcomes after critical illness. She serves as Co-Chair of the Surviving Sepsis Campaign Guidelines, as a council member of the International Sepsis Forum, and on the advisory board of Sepsis Alliance.
Laura Evans, MD, MSc
Professor, Division of Pulmonary, Critical Care, and Sleep Medicine; Medical Director, Critical Care
University of Washington Medical Center
Laura Evans, MD, MSc, is a professor of medicine at the University of Washington and the Medical Director of Critical Care at the University of Washington Medical Center. Her interests focus on sepsis and preparedness for high-consequence infectious diseases, particularly on guideline development and implementation, as well as patient safety/quality improvement.
Dr. Evans earned her medical degree at the University of Michigan and did her residency in internal medicine at Columbia University. She completed pulmonary and critical care medicine fellowship training and earned a Master of Science in epidemiology at the University of Washington. She then joined the New York University and Bellevue Hospital faculty in 2006. In her role there, she led the evacuation of the Bellevue Hospital intensive care units in the aftermath of Hurricane Sandy. She was the clinical lead for New York City’s only patient with Ebola. She was associate program director for the pulmonary and critical care fellowship program at NYU for more than 10 years. After 14 years in NYC, she returned to Seattle in 2019.
She joined the steering committee of the Surviving Sepsis Campaign (SSC) in 2012 and was the co-chair of the past two revisions of the SSC adult sepsis guidelines and SSC COVID management guidelines co-chair. She also served as the critical care team lead for the National Institutes of Health COVID Management Guidelines. She is the current chair of the American Board of Internal Medicine’s Critical Care Medicine specialty board.
Nicholas Mohr, MD, MS
Professor of Emergency Medicine, Anesthesia Critical Care, and Epidemiology
University of Iowa Carver College of Medicine
Nick Mohr, MD, MS, is a Professor of Emergency Medicine, Anesthesia Critical Care, and Epidemiology at the University of Iowa Carver College of Medicine. Dr. Mohr’s research focuses on strategies of implementing high-quality regionalized technology-enabled sepsis care, and his work has been funded by the National Institutes of Health, Agency for Healthcare Research and Quality, Health Resources and Services Administration, Veterans Administration, and the Centers for Disease Control and Prevention.
Joanna Lejnieks, MSN, RN, CCRN
Sepsis Program Manager
Hoag Hospital
Joanna (Jodee) Lejnieks, MSN, RN, CCRN, is a nursing professional and sepsis leader specializing in early recognition and treatment of sepsis. Her 17 years of nursing includes a clinical background spanning medical-surgical nursing, critical care, and rapid response/sepsis nurse roles. She served as a Nurse Educator in both hospital-based and academic settings and currently directs sepsis quality improvement initiatives as Sepsis Program Manager at Hoag Memorial Hospital Presbyterian.
She earned her Associate Degree in Nursing from Golden West College School of Nursing, Bachelor of Science from UC Davis, and Master of Science in Nursing from Vanguard University of Southern California. She serves as AACN’s Sepsis Liaison, has lectured nationally, and is a co-author of the Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026.Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
All individuals in control of content for this activity disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Join the authors of the 2026 Surviving Sepsis Campaign (SSC) Adult Guidelines for a conversational fireside chat highlighting the latest updates to the global recommendations.
Description:
Date: Thursday, April 9, 2026
Time: 11:00 am - 12:00 pm ET / 8:00 - 9:00 am PT
Have questions about the new 2026 Surviving Sepsis Campaign Adult Guidelines? Don’t miss this chance to chat with some of the clinicians responsible for these updates.
Join the authors of the 2026 Surviving Sepsis Campaign (SSC) Adult Guidelines for a conversational chat highlighting the latest updates to the global recommendations. The session will begin with a brief overview of how the multidisciplinary, internationally representative panels developed the new guidelines. Faculty will then outline the most significant changes since 2021 and the evidence that informed those updates. The discussion will focus on how the revised recommendations shape early recognition and management of sepsis and septic shock across diverse care settings. Practical insights on applying the guidelines, including considerations for low‑resource environments, will help participants translate the updates into everyday practice.
There will also be ample time for audience questions during the live session.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the development process for the 2026 Surviving Sepsis Campaign (SSC) Adult Guidelines, including how multidisciplinary and global perspectives informed the recommendations;
- Interpret the updated recommendations and their implications for early recognition and management of sepsis and septic shock across diverse clinical settings;
- Apply practical strategies for implementing the guideline updates in everyday practice, including considerations for adapting care in low‑resource environments;
- Identify key updates and changes from the 2021 guidelines and the evidence that shaped these revisions.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Hallie Prescott, MD, MSc
Professor of Internal Medicine, Division of Pulmonary Critical Care
University of Michigan
Hallie Prescott, MD, MSc, is a Professor of Internal Medicine in the Division of Pulmonary Critical Care within Michigan Medicine and a Staff Physician at the Ann Arbor Veterans Affairs Medical Center. She is the physician lead on the HMS Sepsis and Mi-COVID19 Initiatives. Hallie completed medical school, residency, and chief residency at Ohio State University, and fellowship and Masters in Health Services Research at the University of Michigan. She is interested in sepsis, performance measurement, and long-term outcomes after critical illness. She serves as Co-Chair of the Surviving Sepsis Campaign Guidelines, as a council member of the International Sepsis Forum, and on the advisory board of Sepsis Alliance.
Laura Evans, MD, MSc
Professor, Division of Pulmonary, Critical Care, and Sleep Medicine; Medical Director, Critical Care
University of Washington Medical Center
Laura Evans, MD, MSc, is a professor of medicine at the University of Washington and the Medical Director of Critical Care at the University of Washington Medical Center. Her interests focus on sepsis and preparedness for high-consequence infectious diseases, particularly on guideline development and implementation, as well as patient safety/quality improvement.
Dr. Evans earned her medical degree at the University of Michigan and did her residency in internal medicine at Columbia University. She completed pulmonary and critical care medicine fellowship training and earned a Master of Science in epidemiology at the University of Washington. She then joined the New York University and Bellevue Hospital faculty in 2006. In her role there, she led the evacuation of the Bellevue Hospital intensive care units in the aftermath of Hurricane Sandy. She was the clinical lead for New York City’s only patient with Ebola. She was associate program director for the pulmonary and critical care fellowship program at NYU for more than 10 years. After 14 years in NYC, she returned to Seattle in 2019.
She joined the steering committee of the Surviving Sepsis Campaign (SSC) in 2012 and was the co-chair of the past two revisions of the SSC adult sepsis guidelines and SSC COVID management guidelines co-chair. She also served as the critical care team lead for the National Institutes of Health COVID Management Guidelines. She is the current chair of the American Board of Internal Medicine’s Critical Care Medicine specialty board.
Nicholas Mohr, MD, MS
Professor of Emergency Medicine, Anesthesia Critical Care, and Epidemiology
University of Iowa Carver College of Medicine
Nick Mohr, MD, MS, is a Professor of Emergency Medicine, Anesthesia Critical Care, and Epidemiology at the University of Iowa Carver College of Medicine. Dr. Mohr’s research focuses on strategies of implementing high-quality regionalized technology-enabled sepsis care, and his work has been funded by the National Institutes of Health, Agency for Healthcare Research and Quality, Health Resources and Services Administration, Veterans Administration, and the Centers for Disease Control and Prevention.
Joanna Lejnieks, MSN, RN, CCRN
Sepsis Program Manager
Hoag Hospital
Joanna (Jodee) Lejnieks, MSN, RN, CCRN, is a nursing professional and sepsis leader specializing in early recognition and treatment of sepsis. Her 17 years of nursing includes a clinical background spanning medical-surgical nursing, critical care, and rapid response/sepsis nurse roles. She served as a Nurse Educator in both hospital-based and academic settings and currently directs sepsis quality improvement initiatives as Sepsis Program Manager at Hoag Memorial Hospital Presbyterian.
She earned her Associate Degree in Nursing from Golden West College School of Nursing, Bachelor of Science from UC Davis, and Master of Science in Nursing from Vanguard University of Southern California. She serves as AACN’s Sepsis Liaison, has lectured nationally, and is a co-author of the Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026.Sepsis Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Sepsis Alliance designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.
All individuals in control of content for this activity disclosed no relevant financial relationships.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.